FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000499406> ?p ?o ?g. }

• W2000499406 endingPage "2349" @default.
• W2000499406 startingPage "2343" @default.
• W2000499406 abstract "The majority of patients with polycystic ovary syndrome (PCOS) exhibit an increase in both the frequency and amplitude of LH secretion, which is thought to contribute to the hyperandrogenism associated with this disorder. The increase in LH pulse amplitude may reflect either enhanced pituitary sensitivity to GnRH and/or an increase in hypothalamic GnRH secretion. To determine whether endogenous GnRH secretion is increased in PCOS and to document the degree and time course of androgen suppression after acute LH inhibition, the Nal-Glu GnRH antagonist was administered s.c. at 4 doses (5, 15, 50, and 150 micrograms/kg) to 11 women with PCOS. The response to GnRH receptor blockade was compared with data from regularly cycling women (n = 50) studied in the early and late follicular, and early luteal phases. The response to more prolonged GnRH receptor blockade was determined in a subset of patients, in whom 150 micrograms/kg of the GnRH antagonist was administered s.c. every 24 h for 3 days (n = 7) and continued for 7 days in 3 subjects. LH levels decreased in a dose-dependent fashion after administration of the GnRH antagonist (P < 0.0001), with a maximum percent inhibition of 83 +/- 2%. At all except the 5 micrograms/kg dose, mean LH levels remained significantly lower than baseline for up to 20 h post antagonist (P < 0.002). At all antagonist doses, both the degree and duration of LH suppression were similar in PCOS and normal women. The maximum percent inhibition of FSH was 39 +/- 2%, which was significantly less than that of LH (P < 0.001). Testosterone (T) levels fell significantly within 4 h of antagonist administration, with maximum percent inhibition of 39 +/- 3% occurring at 8 h. In the patients in whom 150 micrograms/kg of the antagonist was given for 3-7 days, no further suppression of either gonadotropins or T was noted. Our conclusions were: 1) The equivalent susceptibility of LH to submaximal GnRH receptor blockade in normal and PCOS women suggests that the elevated LH levels in PCOS are not the result of an increase in the quantity of GnRH secreted. These data imply that it is the frequency of GnRH stimulation per se and/or enhanced pituitary sensitivity to endogenous GnRH that underlie the gonadotropin abnormalities in PCOS; and 2) The rapid suppression of T with increasing GnRH antagonist dose is consistent with acute regulation of T secretion by LH." @default.
• W2000499406 created "2016-06-24" @default.
• W2000499406 creator A5002379637 @default.
• W2000499406 creator A5054197809 @default.
• W2000499406 creator A5060068556 @default.
• W2000499406 creator A5086968407 @default.
• W2000499406 date "1998-07-01" @default.
• W2000499406 modified "2023-10-18" @default.
• W2000499406 title "Use of a Gonadotropin-Releasing Hormone Antagonist as a Physiologic Probe in Polycystic Ovary Syndrome: Assessment of Neuroendocrine and Androgen Dynamics1" @default.
• W2000499406 cites W115314915 @default.
• W2000499406 cites W140074805 @default.
• W2000499406 cites W1604429075 @default.
• W2000499406 cites W1968003395 @default.
• W2000499406 cites W1969062482 @default.
• W2000499406 cites W1973015402 @default.
• W2000499406 cites W1976258169 @default.
• W2000499406 cites W1976826211 @default.
• W2000499406 cites W1988280017 @default.
• W2000499406 cites W1989700537 @default.
• W2000499406 cites W1999061392 @default.
• W2000499406 cites W1999301533 @default.
• W2000499406 cites W2007563635 @default.
• W2000499406 cites W2012487549 @default.
• W2000499406 cites W2013193315 @default.
• W2000499406 cites W2013495676 @default.
• W2000499406 cites W2020998291 @default.
• W2000499406 cites W2023844033 @default.
• W2000499406 cites W2035004241 @default.
• W2000499406 cites W2044603843 @default.
• W2000499406 cites W2046276603 @default.
• W2000499406 cites W2049987798 @default.
• W2000499406 cites W2050183502 @default.
• W2000499406 cites W2056362329 @default.
• W2000499406 cites W2056495111 @default.
• W2000499406 cites W2058366027 @default.
• W2000499406 cites W2068905948 @default.
• W2000499406 cites W2070535031 @default.
• W2000499406 cites W2092403978 @default.
• W2000499406 cites W2093509517 @default.
• W2000499406 cites W2105624384 @default.
• W2000499406 cites W2115195541 @default.
• W2000499406 cites W2122941763 @default.
• W2000499406 cites W2128224630 @default.
• W2000499406 cites W2132835398 @default.
• W2000499406 cites W2137934764 @default.
• W2000499406 cites W2155995048 @default.
• W2000499406 cites W2159626194 @default.
• W2000499406 cites W217568921 @default.
• W2000499406 cites W2316958484 @default.
• W2000499406 cites W2340325966 @default.
• W2000499406 cites W2423385829 @default.
• W2000499406 doi "https://doi.org/10.1210/jcem.83.7.4925" @default.
• W2000499406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9661606" @default.
• W2000499406 hasPublicationYear "1998" @default.
• W2000499406 type Work @default.
• W2000499406 sameAs 2000499406 @default.
• W2000499406 citedByCount "24" @default.
• W2000499406 countsByYear W20004994062012 @default.
• W2000499406 countsByYear W20004994062013 @default.
• W2000499406 countsByYear W20004994062014 @default.
• W2000499406 countsByYear W20004994062015 @default.
• W2000499406 countsByYear W20004994062016 @default.
• W2000499406 countsByYear W20004994062022 @default.
• W2000499406 countsByYear W20004994062023 @default.
• W2000499406 crossrefType "journal-article" @default.
• W2000499406 hasAuthorship W2000499406A5002379637 @default.
• W2000499406 hasAuthorship W2000499406A5054197809 @default.
• W2000499406 hasAuthorship W2000499406A5060068556 @default.
• W2000499406 hasAuthorship W2000499406A5086968407 @default.
• W2000499406 hasBestOaLocation W20004994061 @default.
• W2000499406 hasConcept C126322002 @default.
• W2000499406 hasConcept C134018914 @default.
• W2000499406 hasConcept C143228043 @default.
• W2000499406 hasConcept C170493617 @default.
• W2000499406 hasConcept C187785154 @default.
• W2000499406 hasConcept C2776885963 @default.
• W2000499406 hasConcept C2777391703 @default.
• W2000499406 hasConcept C2777911890 @default.
• W2000499406 hasConcept C2778575703 @default.
• W2000499406 hasConcept C2778782382 @default.
• W2000499406 hasConcept C2778894405 @default.
• W2000499406 hasConcept C2779192864 @default.
• W2000499406 hasConcept C2779306644 @default.
• W2000499406 hasConcept C2780186808 @default.
• W2000499406 hasConcept C3018442814 @default.
• W2000499406 hasConcept C71315377 @default.
• W2000499406 hasConcept C71924100 @default.
• W2000499406 hasConcept C86803240 @default.
• W2000499406 hasConceptScore W2000499406C126322002 @default.
• W2000499406 hasConceptScore W2000499406C134018914 @default.
• W2000499406 hasConceptScore W2000499406C143228043 @default.
• W2000499406 hasConceptScore W2000499406C170493617 @default.
• W2000499406 hasConceptScore W2000499406C187785154 @default.
• W2000499406 hasConceptScore W2000499406C2776885963 @default.
• W2000499406 hasConceptScore W2000499406C2777391703 @default.
• W2000499406 hasConceptScore W2000499406C2777911890 @default.
• W2000499406 hasConceptScore W2000499406C2778575703 @default.
• W2000499406 hasConceptScore W2000499406C2778782382 @default.

• next